AMG
38
-2
SEE
48
2
GILD
28
-2
KMB
39
-6
FLS
53
-2
THC
68
-2
DG
30
2
NEE
42
4
URI
50
-6
TEL
74
9
BXP
34
-4
XRAY
32
-2
PLD
40
-5
ADSK
45
-5
TSN
34
4
DO
62
-7
OXY
50
-3
K
47
2
BEN
40
2
PDCO
72
29
AMG
38
-2
SEE
48
2
GILD
28
-2
KMB
39
-6
FLS
53
-2
THC
68
-2
DG
30
2
NEE
42
4
URI
50
-6
TEL
74
9
BXP
34
-4
XRAY
32
-2
PLD
40
-5
ADSK
45
-5
TSN
34
4
DO
62
-7
OXY
50
-3
K
47
2
BEN
40
2
PDCO
72
29
Financhill
Back

Stoke Therapeutics Stock Predictions

Elon's Secret "A.I. 2.0" Project

Click here now to discover how to claim a stake in Elon's "A.I. 2.0" project
Buy
65

STOK
Stoke Therapeutics

Last Price:
11.66
Seasonality Move:
4.65%

7 Day Trial

ALL ACCESS PASS

$ 7

MarketBeat Alert: Strong sell signal just issued for these 20 stocks

Go here now to get free instant access to all 20 stocks to sell.

Stoke Therapeutics Stock Forecast

  • Over the next 52 weeks, Stoke Therapeutics has on average historically fallen by 0.6% based on the past 4 years of stock performance.
  • Stoke Therapeutics has fallen lower in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Stoke Therapeutics Stock Undervalued?
    The current Stoke Therapeutics [STOK] share price is $11.74. The Score for STOK is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • STOK is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Stoke Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Stoke Therapeutics has on average historically fallen by 0.6% based on the past 4 years of stock performance.

Stoke Therapeutics Stock Rating

Buy
65
Stoke Therapeutics (STOK) is a Buy

Is Stoke Therapeutics overpriced?

  • Stoke Therapeutics has fallen lower in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Stoke Therapeutics Stock Price History

Is STOK stock going to rise?

  • The current trend is moderately bullish and STOK is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
stoketherapeutics.com

52-Week Data

52-Week High:
16.40
52-Week Low:
3.35

Prediction Charts

Market Cap:
543.37M
Price in USD:
11.74
Volume:
692.27K
Beta:
0.76

Technical Analysis

SMA50:
8.28
SMA100:
6.57
SMA200:
6.09
52-Wk Change:
29.81%

Stock Predictions

  • Is Stoke Therapeutics stock public?
    Yes, Stoke Therapeutics is a publicly traded company.
  • What is the Stoke Therapeutics stock quote today?
    The Stoke Therapeutics stock price is 11.74 USD today.
  • How to buy Stoke Therapeutics stock online?
    You can buy Stoke Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-28 14.19 13.50 14.25 12.20
Apr-1 13.22 13.49 13.64 12.59
Apr-2 13.10 13.08 13.10 12.00
Apr-3 13.04 12.83 13.49 12.33
Apr-4 13.05 12.17 13.89 11.77
Apr-5 12.18 12.57 12.86 11.80
Apr-8 12.70 13.00 13.49 12.52
Apr-9 13.00 12.82 13.30 12.18
Apr-10 12.31 12.76 13.01 12.20
Apr-11 12.88 13.50 13.61 12.41
Apr-12 13.35 12.77 13.82 12.54
Apr-15 12.81 12.24 12.87 12.00
Apr-16 12.00 12.45 12.76 11.81
Apr-17 12.51 11.74 12.97 11.63

Stoke Therapeutics Earnings

Stoke Therapeutics Earnings Report: Per Share Stoke Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Stoke Therapeutics Forecast Revenue Growth

Stoke Therapeutics Stock Analysis: Historical quarterly revenues per share for Stoke Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and a decrease next year of $0.22 per share.

* Stoke Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.